Cargando…
Novel Targeted Therapeutic Strategies for Ewing Sarcoma
SIMPLE SUMMARY: Ewing sarcoma is an uncommon cancer that arises in mesenchymal tissues and represents the second most widespread malignant bone neoplasm after osteosarcoma in children. Therapy has increased the 5-year survival rate in the last 40 years, although the recurrence rate has remained high...
Autores principales: | Fayzullina, Daria, Tsibulnikov, Sergey, Stempen, Mikhail, Schroeder, Brett A., Kumar, Naveen, Kharwar, Rajesh Kumar, Acharya, Arbind, Timashev, Peter, Ulasov, Ilya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032664/ https://www.ncbi.nlm.nih.gov/pubmed/35454895 http://dx.doi.org/10.3390/cancers14081988 |
Ejemplares similares
-
Ewing sarcoma treatment: a gene therapy approach
por: Tsibulnikov, Sergey, et al.
Publicado: (2023) -
FNC: An Advanced Anticancer Therapeutic or Just an Underdog?
por: Fayzullina, Daria, et al.
Publicado: (2022) -
Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor Cells
por: Fayzullina, Darya, et al.
Publicado: (2023) -
Latest developments in the pathobiology of Ewing sarcoma
por: Karlina, Irina, et al.
Publicado: (2022) -
To Explore the Stem Cells Homing to GBM: The Rise to the Occasion
por: Tsibulnikov, Sergey, et al.
Publicado: (2022)